Maria Rudkjær Mikkelsen, Sigrid Bruun Nielsen, Edna Stage, Elisabeth R Mathiesen, Peter Damm
Introduction: The aims of this study were to determine the prevalence of women with gestational diabetes mellitus (GDM) not obtaining HbA1c within the normal range (≤ 5.6%) before delivery and to examine whether elevated HbA1c values are associated with an increased risk of large for gestational age (LGA) infants.
Material and methods: A population of 148 women with singleton pregnancies who had been diagnosed with GDM < 34 weeks, and who had a minimum of two HbA1c tests with a ≥ 3 week interval. They were divided into those obtaining a HbA1c ≤ 5.6%, and those who did not before delivery and further stratified according to baseline HbA1c ≤ or > 5.6%. The primary outcome was LGA infants.
Results: A total of 51 (34%) women did not obtain a HbA1c ≤ 5.6% before delivery. The median HbA1c before delivery was 5.9% versus 5.3% in the two groups. At baseline, body mass index and HbA1c were higher in the women not obtaining the goal (30.9 versus 27.8 kg/m², 5.9% versus 5.1%, both p < 0.01). Women with an elevated HbA1c before delivery had a higher prevalence of LGA infants (adjusted odds ratio (OR) 3.1 (95% confidence interval (CI) 1.3-7.6) and neonatal hypoglycaemia (adjusted OR 6.2 (95% CI 1.3-29.0). Other pregnancy outcomes were similar in the two groups. Stratification according to baseline HbA1c did not seem to change the result.
Conclusion: Women with GDM not obtaining HbA1c within the normal range before delivery had a threefold increased risk of having an LGA infant and a sixfold increased risk of neonatal hypoglycaemia.
Funding: not relevant.
Trial registration: not relevant.
本研究的目的是确定妊娠期糖尿病(GDM)妇女在分娩前HbA1c未达到正常范围(≤5.6%)的患病率,并检查HbA1c升高是否与大胎龄儿(LGA)的风险增加有关。材料和方法:148名被诊断为GDM < 34周的单胎妊娠妇女,至少有两次HbA1c检测,间隔≥3周。将患者分为HbA1c≤5.6%组和分娩前HbA1c≤5.6%组,根据基线HbA1c≤或> 5.6%进一步分层。主要结局为LGA婴儿。结果:共有51名(34%)女性在分娩前HbA1c未达到≤5.6%。分娩前HbA1c中位数为5.9%,而两组为5.3%。基线时,未达到目标的女性体重指数和糖化血红蛋白更高(30.9 vs 27.8 kg/m²,5.9% vs 5.1%, p < 0.01)。分娩前HbA1c升高的妇女有更高的LGA婴儿患病率(校正优势比(OR) 3.1(95%置信区间(CI) 1.3-7.6)和新生儿低血糖(校正优势比(OR) 6.2 (95% CI 1.3-29.0)。两组的其他妊娠结局相似。根据基线HbA1c分层似乎没有改变结果。结论:分娩前HbA1c未在正常范围内的GDM妇女生下LGA婴儿的风险增加了3倍,新生儿低血糖的风险增加了6倍。资金:不相关。试验注册:不相关。
{"title":"High maternal HbA1c is associated with overweight in neonates.","authors":"Maria Rudkjær Mikkelsen, Sigrid Bruun Nielsen, Edna Stage, Elisabeth R Mathiesen, Peter Damm","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The aims of this study were to determine the prevalence of women with gestational diabetes mellitus (GDM) not obtaining HbA1c within the normal range (≤ 5.6%) before delivery and to examine whether elevated HbA1c values are associated with an increased risk of large for gestational age (LGA) infants.</p><p><strong>Material and methods: </strong>A population of 148 women with singleton pregnancies who had been diagnosed with GDM < 34 weeks, and who had a minimum of two HbA1c tests with a ≥ 3 week interval. They were divided into those obtaining a HbA1c ≤ 5.6%, and those who did not before delivery and further stratified according to baseline HbA1c ≤ or > 5.6%. The primary outcome was LGA infants.</p><p><strong>Results: </strong>A total of 51 (34%) women did not obtain a HbA1c ≤ 5.6% before delivery. The median HbA1c before delivery was 5.9% versus 5.3% in the two groups. At baseline, body mass index and HbA1c were higher in the women not obtaining the goal (30.9 versus 27.8 kg/m², 5.9% versus 5.1%, both p < 0.01). Women with an elevated HbA1c before delivery had a higher prevalence of LGA infants (adjusted odds ratio (OR) 3.1 (95% confidence interval (CI) 1.3-7.6) and neonatal hypoglycaemia (adjusted OR 6.2 (95% CI 1.3-29.0). Other pregnancy outcomes were similar in the two groups. Stratification according to baseline HbA1c did not seem to change the result.</p><p><strong>Conclusion: </strong>Women with GDM not obtaining HbA1c within the normal range before delivery had a threefold increased risk of having an LGA infant and a sixfold increased risk of neonatal hypoglycaemia.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4309"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Unlabelled: </strong>Cochrane systematic reviews with meta-analyses of randomised trials provide guidance for clinical practice and health-care decision-making. In case of disagreements between research evidence and clinical practice, high quality systematic reviews can facilitate implementation or deimplementation of medical interventions into clinical practice. This applies especially to treatment of critically ill patients where interventions are most often costly and the clinical conditions are associated with high mortality.</p><p><strong>Objectives: </strong>To assess the potential benefits or harms of 1) antithrombin III (AT III) for critically ill patients; 2) inhaled nitric oxide (INO) for acute respiratory distress syndrome (ARDS) and acute lung injury (ALI); 3) aerosolized prostacyclin for ARDS and ALI; 4) thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.</p><p><strong>Methods: </strong>We performed four systematic reviews of relevant randomised clinical trials. To quantify the estimated effect of various interventions, we conducted meta-analyses, where appropriate, to determine intervention effects using the Cochrane Collaboration methodology, trial sequential analyses (TSA), the GRADE, and the PRISMA-guidelines when conducting our systematic reviews. All reviews were performed according to published protocols following the recommendations of the Cochrane Handbook for systematic reviews of interventions. We performed multiple subgroup and sensitivity analyses with regard to methodological quality and various clinical outcomes. Trials were identified through Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE Science Citation Index-Expanded, The Chinese Biomedical Database and LILACS. We included all randomized clinical trials. We hand-searched reference lists, reviews, and contacted authors and experts for additional trials. We searched ClinicalTrials.gov, Centre Watch Clinical Trials Listing Service and ControlledTrials.com for missed, unreported, or ongoing trials. We screened bibliographies of relevant articles and conference proceedings and wrote to trialists and pharmaceutical companies producing the drugs in question.</p><p><strong>Results: </strong>Four systematic reviews included a total of 44 trials with 5,551 patients. Only 15 of the trials were classified as trials with low risk of bias (high methodological quality) regarding generation of the allocation sequence, allocation concealment, blinding, follow-up and other types of bias. 1) Compared with placebo or no intervention, AT III did not significantly affect overall mortality (relative risk (RR) 0.96, 95% confidence interval (CI) 0.89 to 1.03). No subgroup analyses on risk of bias, populations of patients, or with and without adjuvant heparin yielded significant results. AT III significantly increased the risk of bleeding events (RR 1.52, 95% CI 1.30 to 1
未标记:Cochrane随机试验荟萃分析系统评价为临床实践和医疗保健决策提供指导。在研究证据和临床实践之间存在分歧的情况下,高质量的系统评价可以促进在临床实践中实施或取消医疗干预措施。这尤其适用于治疗危重病人,在这种情况下,干预措施往往费用高昂,而且临床状况与高死亡率有关。目的:评价1)抗凝血酶III (AT III)对危重患者的潜在利与弊;2)吸入性一氧化氮(INO)治疗急性呼吸窘迫综合征(ARDS)和急性肺损伤(ALI);3)雾化前列环素治疗ARDS和ALI;4)血栓造影(TEG)或血栓弹性测量(ROTEM)监测大量输血患者的血液治疗与常规护理。方法:我们对相关随机临床试验进行了四项系统评价。为了量化各种干预措施的估计效果,在适当的情况下,我们进行了荟萃分析,在进行系统评价时使用Cochrane协作方法、试验序列分析(TSA)、GRADE和prisma指南来确定干预效果。所有的评价都是按照Cochrane手册对干预措施系统评价的建议,按照已发表的方案进行的。我们对方法学质量和各种临床结果进行了多亚组和敏感性分析。试验通过Cochrane中央对照试验注册中心(Central)、MEDLINE、EMBASE科学引文索引扩展、中国生物医学数据库和LILACS进行鉴定。我们纳入了所有随机临床试验。我们手工检索了参考文献列表、综述,并联系了作者和专家进行额外的试验。我们检索了ClinicalTrials.gov、center Watch临床试验列表服务和ControlledTrials.com,查找错过的、未报告的或正在进行的试验。我们筛选了相关文章和会议记录的参考书目,并写信给试验人员和生产有关药物的制药公司。结果:4项系统综述共纳入44项试验,共纳入5551例患者。只有15项试验在分配序列的产生、分配隐藏、盲法、随访和其他类型的偏倚方面被归类为低偏倚风险(方法学质量高)的试验。1)与安慰剂或无干预相比,AT III对总死亡率无显著影响(相对危险度(RR) 0.96, 95%可信区间(CI) 0.89 ~ 1.03)。没有关于偏倚风险、患者群体或使用和不使用辅助肝素的亚组分析产生显著结果。AT III显著增加出血事件的风险(RR 1.52, 95% CI 1.30 ~ 1.78)。2) INO对总死亡率的影响无统计学意义(RR 1.06, 95% CI 0.93 ~ 1.22),在几个亚组和敏感性分析中均无统计学意义,表明结果稳健性。有限的数据表明,INO对通气时间、无呼吸机天数以及在重症监护病房和医院的住院时间没有影响。我们发现在前24小时内氧合有统计学意义但短暂的改善,以PO2与吸入氧的比例表示(平均差(MD) 15.91, 95% CI 8.25至23.56)。然而,INO似乎显著增加了成人肾脏损害的风险(RR 1.59, 95% CI 1.17 - 2.16),但对出血、高血红蛋白或二氧化氮形成的风险没有显著影响。3)我们只发现了一个小的低风险偏倚的儿科试验,研究了雾化前列环素在ALI或ARDS中的作用。基于这些有限的数据,我们无法支持或反驳ALI或ARDS常规使用这种干预措施。4)与标准治疗相比,TEG或ROTEM对总死亡率没有统计学意义(RR 0.77, 95% CI 0.35 ~ 1.72),但只有5项试验提供了死亡率的数据。我们的分析显示TEG或ROTEM对出血量有统计学意义上的影响(MD为-85.05 ml, 95% CI为-140.68至-29.42),但对其他预定结局没有统计学意义上的影响。然而,这种减少是否对患者的临床状况有影响仍不确定。结论:根据现有的证据,我们没有找到可靠的证据来支持评估的免疫凝固干预措施在重症监护中的临床应用。大部分试验存在严重的方法学缺陷,患者数量少,试验持续时间短。
{"title":"Evidence based evaluation of immuno-coagulatory interventions in critical care.","authors":"Arash Afshari","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>Cochrane systematic reviews with meta-analyses of randomised trials provide guidance for clinical practice and health-care decision-making. In case of disagreements between research evidence and clinical practice, high quality systematic reviews can facilitate implementation or deimplementation of medical interventions into clinical practice. This applies especially to treatment of critically ill patients where interventions are most often costly and the clinical conditions are associated with high mortality.</p><p><strong>Objectives: </strong>To assess the potential benefits or harms of 1) antithrombin III (AT III) for critically ill patients; 2) inhaled nitric oxide (INO) for acute respiratory distress syndrome (ARDS) and acute lung injury (ALI); 3) aerosolized prostacyclin for ARDS and ALI; 4) thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.</p><p><strong>Methods: </strong>We performed four systematic reviews of relevant randomised clinical trials. To quantify the estimated effect of various interventions, we conducted meta-analyses, where appropriate, to determine intervention effects using the Cochrane Collaboration methodology, trial sequential analyses (TSA), the GRADE, and the PRISMA-guidelines when conducting our systematic reviews. All reviews were performed according to published protocols following the recommendations of the Cochrane Handbook for systematic reviews of interventions. We performed multiple subgroup and sensitivity analyses with regard to methodological quality and various clinical outcomes. Trials were identified through Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE Science Citation Index-Expanded, The Chinese Biomedical Database and LILACS. We included all randomized clinical trials. We hand-searched reference lists, reviews, and contacted authors and experts for additional trials. We searched ClinicalTrials.gov, Centre Watch Clinical Trials Listing Service and ControlledTrials.com for missed, unreported, or ongoing trials. We screened bibliographies of relevant articles and conference proceedings and wrote to trialists and pharmaceutical companies producing the drugs in question.</p><p><strong>Results: </strong>Four systematic reviews included a total of 44 trials with 5,551 patients. Only 15 of the trials were classified as trials with low risk of bias (high methodological quality) regarding generation of the allocation sequence, allocation concealment, blinding, follow-up and other types of bias. 1) Compared with placebo or no intervention, AT III did not significantly affect overall mortality (relative risk (RR) 0.96, 95% confidence interval (CI) 0.89 to 1.03). No subgroup analyses on risk of bias, populations of patients, or with and without adjuvant heparin yielded significant results. AT III significantly increased the risk of bleeding events (RR 1.52, 95% CI 1.30 to 1","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"B4316"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Previous studies have shown that preoperative bowel preparation does not influence the frequency of postoperative complications after elective open colonic resections. The Danish Colorectal Cancer Group (DCCG) recommends that mechanical bowel preparation (MBP) should be omitted prior to elective colonic resections. Several surveys show that most surgeons use MBP before colorectal surgery. The aim of this survey was to investigate the use of preoperative bowel preparation in elective colonic and rectal resections in Denmark.
Material and methods: The survey was conducted in 2009. A questionnaire on the use of preoperative bowel preparation in elective colonic and rectal resections performed in 2008 was sent to all the departments of surgery that perform colorectal surgery in Denmark.
Results: 34% of the patients received bowel preparation before open colonic resection compared with 81% before open rectal resection. Overall, the frequency of bowel preparation was significantly higher in laparoscopic (63%) than in open surgery (50%).
Conclusion: MBP before elective open colonic resections remains widely used despite the national DCCG guideline. MBP before laparoscopic colorectal resections was more frequently used than before open colorectal resections as MBP before rectal resections was more frequently used than before colonic resections. The need for preoperative bowel preparation in these procedures has yet to be determined.
{"title":"Use of preoperative bowel preparation in elective colorectal surgery in Denmark remains high.","authors":"Julie Andersen, Jens Thorup, Peer Wille-Jørgensen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies have shown that preoperative bowel preparation does not influence the frequency of postoperative complications after elective open colonic resections. The Danish Colorectal Cancer Group (DCCG) recommends that mechanical bowel preparation (MBP) should be omitted prior to elective colonic resections. Several surveys show that most surgeons use MBP before colorectal surgery. The aim of this survey was to investigate the use of preoperative bowel preparation in elective colonic and rectal resections in Denmark.</p><p><strong>Material and methods: </strong>The survey was conducted in 2009. A questionnaire on the use of preoperative bowel preparation in elective colonic and rectal resections performed in 2008 was sent to all the departments of surgery that perform colorectal surgery in Denmark.</p><p><strong>Results: </strong>34% of the patients received bowel preparation before open colonic resection compared with 81% before open rectal resection. Overall, the frequency of bowel preparation was significantly higher in laparoscopic (63%) than in open surgery (50%).</p><p><strong>Conclusion: </strong>MBP before elective open colonic resections remains widely used despite the national DCCG guideline. MBP before laparoscopic colorectal resections was more frequently used than before open colorectal resections as MBP before rectal resections was more frequently used than before colonic resections. The need for preoperative bowel preparation in these procedures has yet to be determined.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4313"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laura Toftegaard Pedersen, Nanna Hasle Bak, Agnete Skovlund Dissing, Birgit H Petersson
Introduction: Female medical students tend to prefer person-oriented specialties characterized by close doctor-patient contact and aspects of care. Conversely, male medical students tend to seek towards specialties with elements of autonomy, technology and "action" . Furthermore, female doctors will outnumber male doctors in Denmark by 2017 and this may have implications for the availability of specialized doctors.
Material and methods: Data derives from a baseline questionnaire pertaining to a Danish follow-up study. A total of 561 first year medical students enrolled in 2006 and 2007 answered the questionnaire. Binary logistic regression analysis was used to calculate odds ratio estimates of the relationship between gender and specialty preference. Variables measuring self-image were included in the analysis as potential mediators.
Results: 47% female and 19% male students pursued personoriented specialties and 46% female and 68% male students pursued technique-oriented specialties. More female students pursued technique-oriented specialties than in 1992. Female students have 69% less probability of choosing a technique-oriented specialty than males. This association is mediated by lack of self-confidence.
Conclusion: If specialty preferences are persistent during medical school, the results suggest that we will face more difficulties recruiting males to person-oriented specialties than females to technique-oriented specialties in the future. Furthermore, when addressing students' specialty preferences, we should consider both self confidence and gender.
{"title":"Gender bias in specialty preferences among Danish medical students: a cross-sectional study.","authors":"Laura Toftegaard Pedersen, Nanna Hasle Bak, Agnete Skovlund Dissing, Birgit H Petersson","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Female medical students tend to prefer person-oriented specialties characterized by close doctor-patient contact and aspects of care. Conversely, male medical students tend to seek towards specialties with elements of autonomy, technology and \"action\" . Furthermore, female doctors will outnumber male doctors in Denmark by 2017 and this may have implications for the availability of specialized doctors.</p><p><strong>Material and methods: </strong>Data derives from a baseline questionnaire pertaining to a Danish follow-up study. A total of 561 first year medical students enrolled in 2006 and 2007 answered the questionnaire. Binary logistic regression analysis was used to calculate odds ratio estimates of the relationship between gender and specialty preference. Variables measuring self-image were included in the analysis as potential mediators.</p><p><strong>Results: </strong>47% female and 19% male students pursued personoriented specialties and 46% female and 68% male students pursued technique-oriented specialties. More female students pursued technique-oriented specialties than in 1992. Female students have 69% less probability of choosing a technique-oriented specialty than males. This association is mediated by lack of self-confidence.</p><p><strong>Conclusion: </strong>If specialty preferences are persistent during medical school, the results suggest that we will face more difficulties recruiting males to person-oriented specialties than females to technique-oriented specialties in the future. Furthermore, when addressing students' specialty preferences, we should consider both self confidence and gender.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4304"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jesper Fenger-Grøn, Morten Thomsen, Kristian Skytte Andersen, Rasmus Gaardskær Nielsen
The use of serotonine reuptake inhibitors (SRIs) is increasing among Danish pregnant women. This systematic review addresses the potential adverse effects on the foetus and child of maternal SRI medication. The literature indicates a slightly increased risk of cardiovascular malformations and persistent pulmonary hypertension of the new-born, while evidence regarding the risk of preterm labour, low birth weight, low Apgar score, prolonged QT interval and miscarriage is less clear. An estimated 20-30% of infants will have neonatal symptoms following intrauterine SRI exposure. The symptoms may be caused by SRI withdrawal, toxicity or their overlap, but symptom aetiology basically remains controversial. The infants may exhibit neurological, gastrointestinal, autonomic, endocrine or respiratory symptoms. Although the symptoms are self-limited, the families may be seriously affected. In general, studies do not address this important aspect. Evidence concerning long-term effects is surprisingly sparse and many studies have important methodological limitations. However, present evidence does not convincingly indicate detrimental long-term effects. Until sufficient safety studies have been carried out, SRI must be used with caution in pregnancy and every treatment of the pregnant woman should be thoroughly considered.
{"title":"Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.","authors":"Jesper Fenger-Grøn, Morten Thomsen, Kristian Skytte Andersen, Rasmus Gaardskær Nielsen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of serotonine reuptake inhibitors (SRIs) is increasing among Danish pregnant women. This systematic review addresses the potential adverse effects on the foetus and child of maternal SRI medication. The literature indicates a slightly increased risk of cardiovascular malformations and persistent pulmonary hypertension of the new-born, while evidence regarding the risk of preterm labour, low birth weight, low Apgar score, prolonged QT interval and miscarriage is less clear. An estimated 20-30% of infants will have neonatal symptoms following intrauterine SRI exposure. The symptoms may be caused by SRI withdrawal, toxicity or their overlap, but symptom aetiology basically remains controversial. The infants may exhibit neurological, gastrointestinal, autonomic, endocrine or respiratory symptoms. Although the symptoms are self-limited, the families may be seriously affected. In general, studies do not address this important aspect. Evidence concerning long-term effects is surprisingly sparse and many studies have important methodological limitations. However, present evidence does not convincingly indicate detrimental long-term effects. Until sufficient safety studies have been carried out, SRI must be used with caution in pregnancy and every treatment of the pregnant woman should be thoroughly considered.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4303"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"On the use of abciximab in percutaneous coronary intervention.","authors":"Allan Zeeberg Iversen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4312"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Danish longitudinal study of alcoholism 1978-2008. A clinical high-risk study.","authors":"Joachim Knop","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4315"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kirsten Wiese Simonsen, A Carsten Hansen, Dorte Rollmann, Birgitte Kringsholm, Irene Breum Müller, Sys Stybe Johansen, Kristian Linnet
Introduction: We investigated fatal poisonings among drug addicts in 2007. The cause of death, abuse pattern and geographic differences are presented.
Material and methods: All drug-related deaths examined at the three forensic medicine institutes in Denmark in 2007 were evaluated.
Results: The number of drug-related deaths in 2007 was 226. Methadone deaths had increased since 1997 while heroin/morphine deaths decreased. In earlier studies, very few deaths from central stimulants like cocaine and amphetamines occurred (1-1.5%), but in 2007 6% of the deaths were caused by these drugs. Multiple drug use was common. Heroin/morphine, cocaine, amphetamine, cannabis, methadone, benzodiazepines and alcohol were included in the poly-drug use.
Conclusion: This investigation shows stabilization in the number of fatal poisonings in drug addicts. Geographic differences were observed. Methadone was the most frequent cause of fatal poisoning and there was a continuous decrease in heroin/morphine deaths. Fatal deaths from cocaine and amphetamine have increased considerably. Multiple drug use was common.
{"title":"Drug-related death in Denmark in 2007.","authors":"Kirsten Wiese Simonsen, A Carsten Hansen, Dorte Rollmann, Birgitte Kringsholm, Irene Breum Müller, Sys Stybe Johansen, Kristian Linnet","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>We investigated fatal poisonings among drug addicts in 2007. The cause of death, abuse pattern and geographic differences are presented.</p><p><strong>Material and methods: </strong>All drug-related deaths examined at the three forensic medicine institutes in Denmark in 2007 were evaluated.</p><p><strong>Results: </strong>The number of drug-related deaths in 2007 was 226. Methadone deaths had increased since 1997 while heroin/morphine deaths decreased. In earlier studies, very few deaths from central stimulants like cocaine and amphetamines occurred (1-1.5%), but in 2007 6% of the deaths were caused by these drugs. Multiple drug use was common. Heroin/morphine, cocaine, amphetamine, cannabis, methadone, benzodiazepines and alcohol were included in the poly-drug use.</p><p><strong>Conclusion: </strong>This investigation shows stabilization in the number of fatal poisonings in drug addicts. Geographic differences were observed. Methadone was the most frequent cause of fatal poisoning and there was a continuous decrease in heroin/morphine deaths. Fatal deaths from cocaine and amphetamine have increased considerably. Multiple drug use was common.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"A4307"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jan C Vork, Mikkel Brabrand, Lars Folkestad, Kristian Korsgaard Thomsen, Torben Knudsen, Christian Christiansen
Introduction: Political initiatives promoting a more efficient emergency admission process have triggered a reorganisation of the Danish health system with a view to creating fewer and larger admission units counting more experienced physicians. At our hospital, a medical admission unit (MAU) was established. We present the effect of this on the length of hospital stay, mortality rates and the number of readmissions for the last year with the previous structure and the first year of the new MAU structure.
Material and methods: We retrospectively extracted data from the hospital databases on two periods: one year before and the first year after establishment of the MAU.
Results: After establishment of the MAU, the overall average length of hospital stay was reduced from 4.1 to 3.8 days (p < 0.01). No increase in mortality either in-house or within 30 days after discharge was seen. A substantial reduction (26%) in the overall number of readmissions within 30 days after discharge was observed.
Conclusion: The establishment of the MAU improved efficacy at the hospital owing to reduction in the length of hospital stay and the number of readmissions. As judged from mortality rates and indicated by readmission rates, neither the quality of treatment nor patient safety was compromised in a setup, where patients with suspected cardiac diseases are admitted along with patients suspected to suffer from other internal medical diseases. The dynamics between multidisciplinary physicians and nurses seems to improve when they are working close to each other in a setting where team spirit evolves.
{"title":"A medical admission unit reduces duration of hospital stay and number of readmissions.","authors":"Jan C Vork, Mikkel Brabrand, Lars Folkestad, Kristian Korsgaard Thomsen, Torben Knudsen, Christian Christiansen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Political initiatives promoting a more efficient emergency admission process have triggered a reorganisation of the Danish health system with a view to creating fewer and larger admission units counting more experienced physicians. At our hospital, a medical admission unit (MAU) was established. We present the effect of this on the length of hospital stay, mortality rates and the number of readmissions for the last year with the previous structure and the first year of the new MAU structure.</p><p><strong>Material and methods: </strong>We retrospectively extracted data from the hospital databases on two periods: one year before and the first year after establishment of the MAU.</p><p><strong>Results: </strong>After establishment of the MAU, the overall average length of hospital stay was reduced from 4.1 to 3.8 days (p < 0.01). No increase in mortality either in-house or within 30 days after discharge was seen. A substantial reduction (26%) in the overall number of readmissions within 30 days after discharge was observed.</p><p><strong>Conclusion: </strong>The establishment of the MAU improved efficacy at the hospital owing to reduction in the length of hospital stay and the number of readmissions. As judged from mortality rates and indicated by readmission rates, neither the quality of treatment nor patient safety was compromised in a setup, where patients with suspected cardiac diseases are admitted along with patients suspected to suffer from other internal medical diseases. The dynamics between multidisciplinary physicians and nurses seems to improve when they are working close to each other in a setting where team spirit evolves.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"A4298"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30065525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.","authors":"Anne Sofie Astrup","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4152"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}